Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease

Movement Disorders

Volumn 21, Issue 3, 2006, Pages 380-384

  Nomura, Takashi ^a,b   Inoue, Yuichi ^c   Miyake, Masahiro ^a   Yasui, Kenichi ^a   Nakashima, Kenji ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b National Hospital Organisation Yonago Medical Center   (Japan)

^c NEUROPSYCHIATRIC RESEARCH INSTITUTE   (Japan)

Author keywords

Iron; Parkinson's disease; Pittsburg Sleep Quality Index; Prevalence; Restless legs syndrome

Indexed keywords

AMANTADINE; BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PERGOLIDE; TALIPEXOLE; TRIHEXYPHENIDYL;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REGIMEN; FAMILY HISTORY; FEMALE; HUMAN; INTERVIEW; JAPAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SLEEP DISORDER; STATISTICAL ANALYSIS;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; RESTLESS LEGS SYNDROME;

EID: 33645549315     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20734     Document Type: Article

References (26)

1. Ekbom KA. Restless legs syndrome. Neurology 1960;10:863-873.
2. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly populations: the MEMO Study. Memory and morbidity in Augsburg elderly. Neurology 2000;54:1064-1068.
3. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994;17:739-743.
4. Chokroverty S, Jankovic J. Restless legs syndrome: a disease in search of identity. Neurology 1999;52:907-910.
5. Tan EK, Seah A, See SJ, et al. Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord 2001;16:577-579.
6. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002;53:547-554.
7. Desautels A, Turecki G, Montplaisir J, et al. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet 2001;69:1266-1270.
8. Zucconi M, Ferini-Strambi L. Epidemiology and clinical findings of restless legs syndrome. Sleep Med 2004;5:293-299.
9. Gigli GL, Adorati M, Dolso P, et al. Restless legs syndrome in end-stage renal disease. Sleep Med 2004;5:309-315.
10. Manconi M, Govoni V, De Vito A, et al. Pregnancy as a risk factor for restless legs syndrome. Sleep Med 2004;5:305-308.
11. Salih AM, Gray RE, Mills KR, Webley M. A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis. Br J Rheumatol 1994;33:60-63.
12. Littner MR, Kushida C, Anderson WM, et al. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 2004;27;557-559.
13. Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson disease and restless leg syndrome. Arch Neurol 2002;59:421-424.
14. Garcia-Borreguero D, Odin P, Serrano C. Restless legs syndrome and PD: a review of the evidence for a possible association. Neurology 2003;61:S49-S55.
15. Krishnan PR, Bhatia M, Behari M. Restless leg syndrome in Parkinson's disease: a case-controlled study. Mov Disord 2003;18: 181-185.
16. Tan EK, Lum SY, Wong MC. Restless legs syndrome in Parkinson's disease. J Neurol Sci 2002;196:33-36.
17. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
18. Doi Y, Minowa M, Uchiyama M, et al. Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI) in psychiatric disordered and control subjects. Psychiatry Research 2000;97:165-172.
19. Allen RP, Picchietti D, Hening WA, et al; Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-119.
20. Hasegawa K. [The new Parkinson's disease drugs.] Nippon Rinsho 2000;58:2066-2071. In Japanese.
21. The International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless leg syndrome. Sleep Med 2003;4:121-132.
22. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP. Iron and the restless legs syndrome. Sleep 1998;21:371-377.
23. Pal PK, Thennarasu K, Fleming J, et al. Nocturnal sleep disturbance and daytime dysfunction in patients with Parkinson's disease and in their caregivers. Parkinsonism Relat Disord 2004;10:157-168.
24. Smith MC, Ellgring H, Oertel WH. Sleep disturbances in Parkinson's disease patients and spouse. J Am Geriatr Soc 1997;45:194-199.
25. Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 1990;5:280-285.
26. Yodium M, Ben-Schacher D, Ashkenazi R, et al. Brain iron and dopamine receptor function. In: Mandel P, De Feudis F, editors. CNS receptors - from molecular pharmacology to behavior. New York: Raven Press; 1983. p 309-321.